LINDSAY KELLOGG: Open Payments
NPI 1003362195 · RANDOLPH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,122 in 45 payments from 25 companies in 2025. Trend: 2023 $958 · 2024 $899 · 2025 $1,122
Food & beverage: $1,000Education: $122
| Company | Payments | Amount |
|---|---|---|
| Exelixis Inc. | 1 | $125 |
| GENZYME CORPORATION | 1 | $122 |
| ABBVIE INC. | 6 | $99 |
| Daiichi Sankyo Inc. | 2 | $98 |
| Novartis Pharmaceuticals Corporation | 4 | $75 |
| Genmab U.S., Inc. | 3 | $68 |
| Janssen Biotech, Inc. | 3 | $56 |
| Genentech USA, Inc. | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 1 | $43 |
| Merck Sharp & Dohme LLC | 2 | $42 |
Products named: ENHERTU, CABOMETYX, WAYRILZ, Epkinly, Polivy, KEYTRUDA, DARZALEX, BRAFTOVI.
Industry payments across NJ — which companies pay providers there.
